about
Current issues and future directions of oncolytic adenoviruses.Increasing the efficacy of oncolytic adenovirus vectorsMyxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.Oncolytic (replication-competent) adenoviruses as anticancer agents.International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Virology- and immunology-based gene therapy for cancer.
@ast
Virology- and immunology-based gene therapy for cancer.
@en
type
label
Virology- and immunology-based gene therapy for cancer.
@ast
Virology- and immunology-based gene therapy for cancer.
@en
prefLabel
Virology- and immunology-based gene therapy for cancer.
@ast
Virology- and immunology-based gene therapy for cancer.
@en
P2093
P1476
Virology- and immunology-based gene therapy for cancer
@en
P2093
Guangyu Ma
Hideaki Shimada
Kiyoko Kawamura
Masatoshi Tagawa
Nobuo Suzuki
Osamu Shimozato
Takenori Ochiai
P2888
P304
P356
10.1007/S00262-006-0173-3
P50
P577
2006-05-12T00:00:00Z